The KD was particularly effective in patients with DEE caused by SCN2A, STXBP1, KCNQ2, and SCN1A mutations and was not effective in patients with DEE caused by CDKL5 mutations. Here, SCN1A is linked to developmental and epileptic encephalopathy.